Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
02/22/1994 | US5288709 Erythromycin derivatives |
02/22/1994 | US5288704 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
02/22/1994 | US5288703 Administering syngeristic mixture of animal growth regulator and glutamine |
02/22/1994 | US5288693 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents |
02/22/1994 | US5288615 Methods for preparing proteins of altered structure |
02/22/1994 | US5288605 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
02/22/1994 | US5288507 Administering lysine salt of ibuprofen; enantiomorphs with aluminum and magnesium hydroxide |
02/22/1994 | US5288505 Beads containing diltiazem and wetting agent coated with microporous membrane of water dispersible polymer and adjuvant |
02/22/1994 | US5288502 Drug delivery |
02/22/1994 | US5288498 Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
02/22/1994 | US5288497 Compositions of oral dissolvable medicaments |
02/22/1994 | US5288496 Administering steroid in injectable biodegradable polymer matrix |
02/22/1994 | US5288492 Decongestant composition containing aloe vera |
02/22/1994 | CA2104567A1 Fatty acid treatment |
02/22/1994 | CA2104566A1 Fatty acid treatment |
02/22/1994 | CA2104551A1 Oxygenated heterocyclic compounds |
02/22/1994 | CA1327205C Process for the manufacture of camomile oil having high poly-ynes content |
02/22/1994 | CA1327204C2 Benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
02/22/1994 | CA1327202C Substituted 1,3,4,9-tetrahydropyrano ¬3,4-b|indole-1-acetic acids |
02/22/1994 | CA1327200C Urea derivatives |
02/22/1994 | CA1327198C Quinolonecarboxylic acid derivatives and their preparation |
02/22/1994 | CA1327164C Film coated ranitidine hydrochloride tablet |
02/22/1994 | CA1327163C Anxiolytically active piperazine derivatives |
02/21/1994 | EP0594624A4 Dynemicin analogs: syntheses, methods of preparation and use. |
02/21/1994 | CA2104085A1 Process for the production of 1-unsubstituted 3-aminopyrroles |
02/21/1994 | CA2103824A1 Hydrazono-5.beta., 14.beta.-androstane derivatives active on the car diovascular system, processes for their preparation and pharmaceutical compositions containing same |
02/21/1994 | CA2101809A1 Cytotoxic drug conjugates for treatment of neoplastic diseases |
02/19/1994 | CA2104051A1 Deoxymyoinositol derivatives, process for their preparation and their use in medicaments |
02/19/1994 | CA2104049A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments |
02/18/1994 | CA2104042A1 Method of treating immunoinflammatory disease |
02/18/1994 | CA2103644A1 Method for preventing and treating atherosclerosis |
02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
02/17/1994 | WO1994003500A1 Glucans with immunostimulant activity |
02/17/1994 | WO1994003485A1 Peptide lung surfactants and therapeutic combinations |
02/17/1994 | WO1994003482A1 Glycyl-hystidyle-lysine (ghl) derivatives |
02/17/1994 | WO1994003476A1 17β-SUBSTITUTED 4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES |
02/17/1994 | WO1994003475A1 FLUORINATED 17β-SUBSTITUTED 4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES |
02/17/1994 | WO1994003474A1 Steroids with a fluorinated acylureidic type side chain |
02/17/1994 | WO1994003469A1 New derivatives of neuraminic acid |
02/17/1994 | WO1994003467A2 Antiretroviral enantiomeric nucleotide analogs |
02/17/1994 | WO1994003465A1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs |
02/17/1994 | WO1994003463A1 Phosphonoacetic esters and acids as anti-inflammatories |
02/17/1994 | WO1994003456A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties |
02/17/1994 | WO1994003455A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
02/17/1994 | WO1994003452A1 Methanesulphonate |
02/17/1994 | WO1994003451A1 Quinuclidine derivatives as squalene synthase inhibitors |
02/17/1994 | WO1994003450A1 Furylthiazole and their use as h2-receptor antagonists and antimicrobial agents |
02/17/1994 | WO1994003448A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
02/17/1994 | WO1994003447A1 Benzodiazepine derivatives |
02/17/1994 | WO1994003446A1 4-substituted 1,2,4-triazole derivatives |
02/17/1994 | WO1994003445A1 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists |
02/17/1994 | WO1994003444A1 Amide derivatives |
02/17/1994 | WO1994003442A1 3- and 5-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof, a pharmaceutical preparation containing said compounds and the use of said compounds for the preparation of medicaments |
02/17/1994 | WO1994003440A1 Benzoxazinones as inhibitors of hiv reverse transcriptase |
02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
02/17/1994 | WO1994003436A1 Novel piprazine carboxamides |
02/17/1994 | WO1994003435A1 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
02/17/1994 | WO1994003433A1 BIOLOGICAL APPLICATIONS OF ALKALOIDS DERIVED FROM THE TUNICATE EUDISTOMA sp. |
02/17/1994 | WO1994003431A1 Isoserine derivatives and their use as leukotriene antagonists |
02/17/1994 | WO1994003430A1 Novel pyridyl- and pyrimidylpiperazine derivatives |
02/17/1994 | WO1994003427A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
02/17/1994 | WO1994003426A1 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
02/17/1994 | WO1994003421A2 Esters and combinations of an organic nitrate and a salicylate |
02/17/1994 | WO1994003197A1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin |
02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
02/17/1994 | WO1994003188A1 Ibuprofen-antacid combinations |
02/17/1994 | WO1994003187A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives |
02/17/1994 | WO1994003186A1 Vaginal mucoadhesive gel, medicament containing it and its method of preparation |
02/17/1994 | WO1994003184A1 Compositions for treating and inhibiting gastric and duodenal ulcers |
02/17/1994 | WO1994003183A1 Medicinal composition for inhibiting cancer metastasis to liver and medicinal composition for curing hepatoma |
02/17/1994 | WO1994003182A1 Preparations containing sugars for treating mucous membrane conditions |
02/17/1994 | WO1994003181A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver |
02/17/1994 | WO1994003180A1 Pharmacologically active glycerophosphoderivatives |
02/17/1994 | WO1994003179A1 Crystalline amifostine compositions and methods for the preparation and use of same |
02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
02/17/1994 | WO1994003177A2 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
02/17/1994 | WO1994003176A1 Treatment of alzheimer's disease and modulation of immune system with δ5-androstenes |
02/17/1994 | WO1994003175A1 Use of prostane derivatives of formulae i and ii for the production of a medicament for the treatment of chronic polyarthritis |
02/17/1994 | WO1994003174A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam |
02/17/1994 | WO1994003173A1 Use of 8-(3-oxocyclopentyl)-1,3-dipropyl-7h-purine-2,6-dione for the symptomatic treatment of cystic fibrosis |
02/17/1994 | WO1994003172A1 Remedy for inflammatory intestinal diseases |
02/17/1994 | WO1994003171A1 Cardiac protective |
02/17/1994 | WO1994003170A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
02/17/1994 | WO1994003169A1 Mixture of a free radical scavenger and an iron chelator for the treatment of sickle cell disease |
02/17/1994 | WO1994003168A1 5 s penem derivatives, their preparation and use |
02/17/1994 | WO1994003167A1 Cataract remedy |
02/17/1994 | WO1994003166A1 Ibuprofen-muscle relaxant combinations |
02/17/1994 | WO1994003165A1 Antithrombotic treatment with calix(n)arene compounds |
02/17/1994 | WO1994003164A1 Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds |
02/17/1994 | WO1994003163A1 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
02/17/1994 | WO1994003162A1 Medicaments for the treatment or prevention of elevated intraocular pressure |
02/17/1994 | WO1994003161A1 Controlled release morphine preparation |
02/17/1994 | WO1994003158A1 Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
02/17/1994 | WO1994003156A1 Pharmaceutical and/or cosmetic preparation and the use of the preparation |
02/17/1994 | WO1994003153A1 Surfactant free aerosol formulations containing beclomethasone dipropionate |
02/17/1994 | WO1994003149A2 Lipid-soluble thioethers and dithioethers in cosmetic preparations to counteract aging of the human skin |
02/17/1994 | WO1994003147A1 Oral compositions |
02/17/1994 | WO1994003055A1 Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv |
02/17/1994 | WO1994003054A1 Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen |
02/17/1994 | WO1993020839A3 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |